News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
(USGovernment-News.Com, June 17, 2012 ) New York, NY -- The positive market action seen during the week of June 4 continued last week as well and the DOW posted another gain of 300-plus points, including a rise of 115 points on Friday that set a positive tone through the markets heading into Sunday's Greek elections. Undoubtedly, the results of those elections will shape the trading action during the upcoming week, too.
While the fate of the euro may lie in the hands of Sunday's Greek voters, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies a few other stocks and stories to keep an eye on this week.
Facebook (FB): A six percent price spike on Friday placed Facebook shares to back over the thirty dollar mark and solidified the company's first weekly gain since its much-hyped IPO last month. FB closed the week just under eleven percent higher as the company began outlining its defense to multiple lawsuits filed by investors who bought heavily into the hype and ended up deep in the hole when shares dropped to significantly below their IPO price.
Dendreon Corp (DNDN): What is good news for JNJ could come as another hinderance for Dendreon and its own prostate cancer treatment, Provenge. Once hailed as the usher for the next generation of prostate cancer treatment - and the cancer immunotherapy market as a whole - Provenge has suffered from a slow rampup of sales, due mainly to the high cost of treatment and concerns of reimbursement expressed by both Doctors and patients.
Implant Sciences (IMSC): Shares of Implant Sciences traded with some noticeably higher volume on days last week and with price volatility that indicates investors may be starting to notice the huge potential of this company.
With a cutting-edge explosive and narcotics-detecting technology, Implant could soon set the standard for airport, air cargo and homeland security world wide.
Celsius Holdings (CELH): Trading volume might be growing for Implant Sciences quite a bit this year, but Celsius Holdings is still trading light, aside from a few nice spurts at points during the early months of 2012.
Celsius makes and markets multiple calorie-burning beverages, both carbonated and non-carbonated, and has also made a marketing push with its 'on the go' powdered packets that retain the same qualities of the beverage when added to water. A 30-serving canister of powder is also now on sale at the company's website.
Spectrum Pharmaceuticals (SPPI): Shares of Spectrum Pharmaceuticals enjoyed a solid week after a Friday spike of nearly four percent solidified gains of roughly a buck for the five day period. This company has been a big-time winner over the past year or so. Spectrum has posted gains in revenue that were initially doubted by many who invest in the sector that thought generic competition would put a stop to Spectrum's soaring FUSILEV sales, and has also seen its share price inch higher month after month amid growing short interest.
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, growth stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:
